The first experience of stem cell labeling in Iran using 111In- oxine

Ali Gholamrezanezhad, Mohammad Bagheri, Mehdi Mohammadnezhad, Sahar Mirpour, Jalil Majd Ardekani, Kamran Alimoghadam, Maryam Bashtar, Davood Beiki, Kianoush Ansari Gilani, Mohsen Saghari, Ardeshir Ghavamzadeh, Reza Malekzadeh

Research output: Contribution to journalArticle

Abstract

Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods: After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 μCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results: The labeling efficiency, specific activity and cell viability was 70.6%, 31.70 μCi/106 and 100%, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.

Original languageEnglish (US)
JournalIranian Journal of Nuclear Medicine
Volume15
Issue number28
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Iran
Stem Cells
Mesenchymal Stromal Cells
Cell Survival
Regenerative Medicine
Therapeutic Uses
Cell- and Tissue-Based Therapy
Radio
Cell Biology
Research Personnel
Temperature
indium oxine
Pharmaceutical Preparations
Therapeutics

Keywords

  • In-oxine
  • Labeling
  • Mesenchymal stem cell

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Gholamrezanezhad, A., Bagheri, M., Mohammadnezhad, M., Mirpour, S., Ardekani, J. M., Alimoghadam, K., ... Malekzadeh, R. (2007). The first experience of stem cell labeling in Iran using 111In- oxine. Iranian Journal of Nuclear Medicine, 15(28).

The first experience of stem cell labeling in Iran using 111In- oxine. / Gholamrezanezhad, Ali; Bagheri, Mohammad; Mohammadnezhad, Mehdi; Mirpour, Sahar; Ardekani, Jalil Majd; Alimoghadam, Kamran; Bashtar, Maryam; Beiki, Davood; Gilani, Kianoush Ansari; Saghari, Mohsen; Ghavamzadeh, Ardeshir; Malekzadeh, Reza.

In: Iranian Journal of Nuclear Medicine, Vol. 15, No. 28, 01.12.2007.

Research output: Contribution to journalArticle

Gholamrezanezhad, A, Bagheri, M, Mohammadnezhad, M, Mirpour, S, Ardekani, JM, Alimoghadam, K, Bashtar, M, Beiki, D, Gilani, KA, Saghari, M, Ghavamzadeh, A & Malekzadeh, R 2007, 'The first experience of stem cell labeling in Iran using 111In- oxine', Iranian Journal of Nuclear Medicine, vol. 15, no. 28.
Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Ardekani JM, Alimoghadam K et al. The first experience of stem cell labeling in Iran using 111In- oxine. Iranian Journal of Nuclear Medicine. 2007 Dec 1;15(28).
Gholamrezanezhad, Ali ; Bagheri, Mohammad ; Mohammadnezhad, Mehdi ; Mirpour, Sahar ; Ardekani, Jalil Majd ; Alimoghadam, Kamran ; Bashtar, Maryam ; Beiki, Davood ; Gilani, Kianoush Ansari ; Saghari, Mohsen ; Ghavamzadeh, Ardeshir ; Malekzadeh, Reza. / The first experience of stem cell labeling in Iran using 111In- oxine. In: Iranian Journal of Nuclear Medicine. 2007 ; Vol. 15, No. 28.
@article{e8e28f22bdcb4e559f2c119ff498d585,
title = "The first experience of stem cell labeling in Iran using 111In- oxine",
abstract = "Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods: After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 μCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results: The labeling efficiency, specific activity and cell viability was 70.6{\%}, 31.70 μCi/106 and 100{\%}, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.",
keywords = "In-oxine, Labeling, Mesenchymal stem cell",
author = "Ali Gholamrezanezhad and Mohammad Bagheri and Mehdi Mohammadnezhad and Sahar Mirpour and Ardekani, {Jalil Majd} and Kamran Alimoghadam and Maryam Bashtar and Davood Beiki and Gilani, {Kianoush Ansari} and Mohsen Saghari and Ardeshir Ghavamzadeh and Reza Malekzadeh",
year = "2007",
month = "12",
day = "1",
language = "English (US)",
volume = "15",
journal = "Iranian Journal of Nuclear Medicine",
issn = "1681-2824",
publisher = "Teheran University of Medical Sciences",
number = "28",

}

TY - JOUR

T1 - The first experience of stem cell labeling in Iran using 111In- oxine

AU - Gholamrezanezhad, Ali

AU - Bagheri, Mohammad

AU - Mohammadnezhad, Mehdi

AU - Mirpour, Sahar

AU - Ardekani, Jalil Majd

AU - Alimoghadam, Kamran

AU - Bashtar, Maryam

AU - Beiki, Davood

AU - Gilani, Kianoush Ansari

AU - Saghari, Mohsen

AU - Ghavamzadeh, Ardeshir

AU - Malekzadeh, Reza

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods: After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 μCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results: The labeling efficiency, specific activity and cell viability was 70.6%, 31.70 μCi/106 and 100%, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.

AB - Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods: After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 μCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results: The labeling efficiency, specific activity and cell viability was 70.6%, 31.70 μCi/106 and 100%, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.

KW - In-oxine

KW - Labeling

KW - Mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=45149129175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45149129175&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:45149129175

VL - 15

JO - Iranian Journal of Nuclear Medicine

JF - Iranian Journal of Nuclear Medicine

SN - 1681-2824

IS - 28

ER -